Cystoscopic examination
Conditions
Interventions
Group O1:Oliceridine0.5mg intravenously
Group O2:Oliceridine1mg intravenously
Group S:Sufentanil 50ug intravenously
Sponsors
The Second Hospital of Jilin University
Eligibility
Sex/Gender
All
Age
60 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients whose initial clinical diagnosis is consistent with cystoscopy or treatment indications; Age 60-75 years old; American Society of Anesthesiologists (ASA) grade?—?, and Mallampati airway grade I~?.
Exclusion criteria
Exclusion criteria: There is a serious systemic disease; Allergies to drugs used in this study have a history of alcohol or sedative and analgesic drug abuse; Unable to give fully informed consent due to intellectual or behavioral disabilities; No recent history of cold; No recent anticoagulant medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS Score;Incidence of moderate to severe urinary tract irritation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation success rate;Success rate of lens insertion;Propofol dosage (mg) ;Inspection time (min) ;Incidence of hypoxemia;Incidence of urinary tract irritation ;Incidence of postoperative nausea and vomiting;propofol supplemental times;wake up time (min); | — |
Countries
China
Contacts
Public ContactZhao Peng
The Second Hospital of Jilin University
Outcome results
None listed